Determining breast-cancer stage 
 Chemotherapy and radiation  
 are common treatment  
 options for people  
 who have been diagnosed  
 with cancer. 
 While radiation may be targeted  
 at specific areas, chemotherapy  
 is systemic. This means  
 it affects the entire body. 
 As a result, as chemotherapy  
 kills fast-growing cancer  
 cells,  it  also  kills  or  slows  the  
 growth of healthy cells, including  
 hair  cells,  that  divide  and  
 grow quickly, explains  the National  
 Cancer Institute.  
 When chemotherapy treatment  
 is completed,  the body  is  
 typically  capable  of  regenerating  
 new hair, but that can take  
 some time. 
 Women who consider their  
 hair a large part of their identity  
 may have strong concerns  
 and fears regarding hair loss  
 and what their hair may look  
 like when  it  begins  to  regrow.  
 Understanding what to expect  
 and what they can do to facilitate  
 the  regrowth  of  hair  can  
 help women better handle what  
 lies ahead. 
 New hair typically begins to  
 grow within one to two months  
 of the last chemo treatment.  
 Breastcancer.org says people  
 who have undergone chemotherapy  
 may notice soft fuzz  
 forming on their head roughly  
 two to three weeks after the end  
 of chemo. 
 This  will  be  followed  by  
 real hair growing at its normal  
 rate one month afterward.  
 Two months after the last treatment, 
   an  inch  of  hair  can  be  
 expected. 
 How hair grows back elsewhere  
 on the body, such as the  
 eyelashes, eyebrows and pubic  
 area, varies from person to person. 
 Experts at the Robert H. Lurie  
 Comprehensive Cancer Center’s  
 Dermatologic Care Center  
 at Northwestern University  in  
 Chicago recommend speaking  
 with a doctor  if hair  is not regrowing  
 TIMESLEDGER   |   QNS.30     COM   |   OCT. 9-OCT. 15, 2020 
 quickly, which can be  
 the result of low levels of iron or  
 zinc or even thyroid problems. 
 To help the process along,  
 some doctors suggest the use  
 of supplements like biotin. The  
 National  Institutes  of  Health  
 says biotin is a B vitamin found  
 in many  foods  that  helps  turn  
 carbohydrates, fats, and proteins  
 into energy. 
 There is some evidence that  
 taking  biotin can help  thicken  
 and speed up the growth of hair  
 and nails, but more research is  
 needed. 
 Rogaine, the baldness treatment, 
  also may be advised, as  
 it’s been shown to speed hair  
 regrowth  in  breast  cancer  patients  
 who have lost their hair,  
 advises Health magazine. 
 It is not uncommon for hair  
 grown after chemotherapy to  
 look and feel different from  
 hair prior  to  treatment. Someone  
 who once had straight hair  
 may develop a wavy mane afterwards. 
  While drastic changes  
 are not common, blonde hair  
 may darken. 
 As hair grows in, certain areas  
 on the head may grow faster  
 than  others.  Working  with  
 an experienced stylist can help  
 a person achieve a look that is  
 evened out and stylish at any  
 length. 
 It can be nerve-wracking to  
 wait  for  hair  to  regrow  after  
 chemotherapy. But patience and  
 understanding the road ahead  
 can assuage any fears breast  
 cancer patients may have about  
 regrowing their hair.   
 When receiving treatment  
 for breast cancer,  
 women will learn about  
 cancer staging.  
 According to the nonprofit  
 organization Breastcancer.org,  
 determining the stage of the  
 cancer helps patients and their  
 doctors figure out the prognosis, 
  develop a treatment plan,  
 and even decide if clinical trials  
 are a valid option. 
 Typically expressed as a  
 number on a scale of 0 through  
 IV, breast-cancer stage is determined  
 after careful consideration  
 of a host of factors.  
 The staging system, sometimes  
 referred to as the TNM  
 system, is overseen by the  
 American Joint Committee on  
 Cancer and ensures that all instances  
 of breast cancer are described  
 in a uniform way. 
 This helps to compare treatment  
 results and gives doctors  
 and patients a better understanding  
 of breast cancer and  
 the ways to treat it. 
 Breastcancer.org notes that  
 the TNM system was updated in  
 2018, but before then was based  
 on three clinical characteristics: 
 T: The size of the tumor and  
 whether or not it has grown into  
 nearby tissue. 
 N: Whether the cancer is  
 present in the lymph nodes. 
 M: Whether the cancer has  
 metastasized, or spread to others  
 parts of the body beyond the  
 breast. 
 Each of those factors is still  
 considered when determining  
 breast cancer stage, but starting  
 in 2018, the AJCC added  
 additional characteristics to its  
 staging guidelines, which make  
 staging more complex but also  
 more accurate: 
 Tumor grade  
 This is a measurement of  
 how much the cancer cells look  
 like normal cells. 
 Estrogen- and  
 progesterone-receptor status  
 This indicates if the cancer  
 cells have receptors for the hormones  
 estrogen and progesterone. 
  If cancer cells are deemed  
 estrogen-receptor-positive, then  
 they may receive signals from  
 estrogen that promote their  
 growth. Similarly, those deemed  
 progesterone-receptor-positive  
 may receive signals from progesterone  
 that could promote  
 their growth.  
 Testing for hormone receptors, 
  which roughly two out of  
 three breast cancers are positive  
 for, helps doctors determine if the  
 cancer will respond to hormonal  
 therapy or other treatments.  
 Hormone-receptor-positive cancers  
 may be treatable with medications  
 that reduce hormone  
 production or block hormones  
 from supporting the growth and  
 function of cancer cells. 
 HER2 status  
 This helps doctors determine  
 if the cancer cells are  
 making too much of the HER2  
 protein. HER2 proteins are receptors  
 on breast cells made by  
 the HER2 gene. In about 25 percent  
 of breast cancers, the HER2  
 gene makes too many copies of  
 itself, and these extra genes ultimately  
 make breast cells grow  
 and divide in ways that are  
 uncontrollable. HER2-positive  
 breast cancers are more likely  
 to spread and return than those  
 that are HER2-negative. 
 Oncotype DX score  
 The oncotype DX score helps  
 doctors determine a woman’s  
 risk  of  early  stage,  estrogenreceptor 
 positive breast cancer  
 recurring and how likely she  
 is to benefit from post-surgery  
 chemotherapy. In addition, the  
 score helps doctors figure out  
 if  a woman  is  at  risk  of ductal  
 carcinoma in situ recurring or  
 at risk for a new invasive cancer  
 developing in the same breast.  
 The score also helps doctors  
 figure out if such women will  
 benefit from radiation therapy  
 or DCIS surgery. 
 Determining breast-cancer  
 stage is a complex process, but  
 one that can help doctors develop  
 the most effective course of  
 treatment. More information is  
 available at www.breastcancer. 
 org. 
 Determining the stage of the cancer helps patients and their doctors  
 figure out the prognosis, develop a treatment plan and even  
 decide if clinical trials are a valid option. 
 Regrowing and caring for  
 hair after chemotherapy 
 
				
/Breastcancer.org
		/Breastcancer.org
		/www.breastcancer
		/Breastcancer.org
		/www.breastcancer